Cargando…

Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.

Ocular sebaceous carcinoma (OSC) is an uncommon malignancy with a potential to recur and metastasize. Some characteristics of sebaceous carcinoma, such as female preponderance, shown in the present series during 11-year period at Korea Cancer Center Hospital, led us to study their hormone receptors...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, K. J., Khang, S. K., Koh, J. S., Chung, J. H., Lee, S. S.
Formato: Texto
Lenguaje:English
Publicado: Korean Academy of Medical Sciences 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054683/
https://www.ncbi.nlm.nih.gov/pubmed/11068992
_version_ 1782200005251039232
author Cho, K. J.
Khang, S. K.
Koh, J. S.
Chung, J. H.
Lee, S. S.
author_facet Cho, K. J.
Khang, S. K.
Koh, J. S.
Chung, J. H.
Lee, S. S.
author_sort Cho, K. J.
collection PubMed
description Ocular sebaceous carcinoma (OSC) is an uncommon malignancy with a potential to recur and metastasize. Some characteristics of sebaceous carcinoma, such as female preponderance, shown in the present series during 11-year period at Korea Cancer Center Hospital, led us to study their hormone receptors and c-erbB-2 expression. c-erbB-2 overexpression was very common (83%) in OSC, and was not associated with pathologic findings or clinical outcome. Interestingly, estrogen and progesterone receptor was detected in 4 and 2 cases, respectively, suggesting a role of hormonal influence on this neoplasm. Immunohistochemical and clinicopathologic features of 18 cases of OSC in Korea are presented.
format Text
id pubmed-3054683
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-30546832011-03-15 Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein. Cho, K. J. Khang, S. K. Koh, J. S. Chung, J. H. Lee, S. S. J Korean Med Sci Research Article Ocular sebaceous carcinoma (OSC) is an uncommon malignancy with a potential to recur and metastasize. Some characteristics of sebaceous carcinoma, such as female preponderance, shown in the present series during 11-year period at Korea Cancer Center Hospital, led us to study their hormone receptors and c-erbB-2 expression. c-erbB-2 overexpression was very common (83%) in OSC, and was not associated with pathologic findings or clinical outcome. Interestingly, estrogen and progesterone receptor was detected in 4 and 2 cases, respectively, suggesting a role of hormonal influence on this neoplasm. Immunohistochemical and clinicopathologic features of 18 cases of OSC in Korea are presented. Korean Academy of Medical Sciences 2000-10 /pmc/articles/PMC3054683/ /pubmed/11068992 Text en
spellingShingle Research Article
Cho, K. J.
Khang, S. K.
Koh, J. S.
Chung, J. H.
Lee, S. S.
Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.
title Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.
title_full Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.
title_fullStr Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.
title_full_unstemmed Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.
title_short Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.
title_sort sebaceous carcinoma of the eyelids: frequent expression of c-erbb-2 oncoprotein.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054683/
https://www.ncbi.nlm.nih.gov/pubmed/11068992
work_keys_str_mv AT chokj sebaceouscarcinomaoftheeyelidsfrequentexpressionofcerbb2oncoprotein
AT khangsk sebaceouscarcinomaoftheeyelidsfrequentexpressionofcerbb2oncoprotein
AT kohjs sebaceouscarcinomaoftheeyelidsfrequentexpressionofcerbb2oncoprotein
AT chungjh sebaceouscarcinomaoftheeyelidsfrequentexpressionofcerbb2oncoprotein
AT leess sebaceouscarcinomaoftheeyelidsfrequentexpressionofcerbb2oncoprotein